Kyprolis IV infusion 40mg, manufactured by Ono Pharmaceutical, contains Carfilzomib, a proteasome inhibitor. It is indicated for the treatment of relapsed or refractory multiple myeloma, often in combination with other therapies. This 40mg bottle has a YJ code of 4291433D2022.
Kyprolis IV infusion 40mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →